Soru

Zorluk: Çok zorPreventive Care and Screening

An initial ambulatory care visit is conducted for a 76-year-old male patient who recently relocated to the area to live with his family. He reports feeling well without any acute clinical symptoms. His past medical history is significant for essential hypertension, hyperlipidemia, and mild osteoarthritis. His daily medication regimen consists of lisinopril, atorvastatin, and as-needed acetaminophen. He reports a continuous smoking history of one pack per day starting at age 18 and ending at age 56, maintaining complete abstinence since that time. He denies any lifetime alcohol consumption or recreational drug use. Previous cancer surveillance includes a structurally normal colonoscopy performed 5 years ago at age 71. A detailed review of his state immunization registry and transferred medical records shows the administration of a tetanus-diphtheria-acellular pertussis (Tdap) booster 2 years ago, a seasonal influenza vaccine 2 weeks ago, and a complete two-dose series of the recombinant zoster vaccine at age 66. He has no documented history of receiving a pneumococcal immunization, a respiratory syncytial virus (RSV) immunization, or any serological screening for viral hepatitis. Vital signs are within normal limits, and the physical examination is completely unremarkable.

Based on current evidence-based guidelines, which of the following preventive health interventions should be ordered or administered for this patient today? (Select all that apply.)

  1. Administration of a 20-valent pneumococcal conjugate vaccineCevap
  2. B
    Low-dose computed tomography of the chest
  3. Hepatitis C virus antibody testingCevap
  4. D
    Prostate-specific antigen testing
  5. E
    Ultrasound of the abdomen
  6. Administration of respiratory syncytial virus vaccineCevap

Cevap

The indicated interventions for this patient are Hepatitis C virus antibody testing, administration of a pneumococcal conjugate vaccine, and administration of the respiratory syncytial virus (RSV) vaccine.
Based on current guidelines, three interventions are indicated. First, Hepatitis C testing is recommended once for all adults between the ages of 18 and 79. Second, the RSV vaccine is recommended by the ACIP for all adults aged 75 and older. Third, a pneumococcal conjugate vaccine is indicated for all adults 65 years and older who have not previously received one.

Adım Adım Çözüm

1
Evaluate the patient's age and immunization history against current ACIP guidelines.
At age 76, with no prior record of pneumococcal or RSV vaccination, he is due for both.
ACIP recommends pneumococcal conjugate vaccination for all adults ≥\ge 65 years and RSV vaccination for all adults ≥\ge 75 years.
2
Analyze the patient's age against general USPSTF serological screening guidelines.
He requires a one-time Hepatitis C virus antibody test.
USPSTF recommends one-time HCV screening for all adults aged 18 to 79 years, and he has no record of prior testing.
3
Assess the patient's smoking history and age to determine eligibility for lung and vascular screening.
He is ineligible for both low-dose computed tomography (LDCT) and abdominal aortic aneurysm (AAA) screening.
Although he has a 38 pack-year history, he quit 20 years ago (LDCT requires quitting within the last 15 years). Additionally, at age 76, he exceeds the upper age limit (75 years) for AAA screening.
4
Review indications for prostate cancer screening.
Routine PSA testing should not be ordered.
USPSTF recommends against (Grade D) routine PSA screening for men aged 70 and older.

Anahtar Kavram

Application of precise age cutoffs and time-since-exposure criteria in USPSTF and ACIP preventive guidelines for older adults.
Bu soruyu puanla